Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Cell Reports|October 13, 2016
The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA SortingLaura Santangelo, Giorgio Giurato, Carla Cicchini, et al.
International Journal of Molecular Sciences|February 10, 2024
THBS1 and THBS2 Enhance the In Vitro Proliferation, Adhesion, Migration and Invasion of Intrahepatic Cholangiocarcinoma CellsEleonora Corbella, Claudia Fara, Francesca Covarelli, et al.
RNA Biology|July 5, 2021
The RNA editing enzyme ADAR2 restricts L1 mobilityLoredana Frassinelli, Elisa Orecchini, Sofian Al-Wardat, et al.
Nucleic Acids Research|September 24, 2016
ADAR1 restricts LINE-1 retrotranspositionElisa Orecchini, Margherita Doria, Ambra Antonioni, et al.
Journal of Hepatology|September 11, 2012
TGFβ overrides HNF4α tumor suppressing activity through GSK3β inactivation: implication for hepatocellular carcinoma gene therapyAngela Maria Cozzolino, Tonino Alonzi, Laura Santangelo, et al.
Journal of Hepatology|December 25, 2009
Proteomic analysis reveals a major role for contact inhibition in the terminal differentiation of hepatocytesCarmine Mancone, Beatrice Conti, Laura Amicone, et al.
Proteomics|April 1, 2009
Analysis of the periplasmic proteome of Pseudomonas aeruginosa, a metabolically versatile opportunistic pathogenFrancesco Imperi, Fabiola Ciccosanti, Ariel Basulto Perdomo, et al.
Journal of Proteome Research|March 27, 2012
Ferritin heavy chain is the host factor responsible for HCV-induced inhibition of apoB-100 production and is required for efficient viral infectionCarmine Mancone, Claudia Montaldo, Laura Santangelo, et al.
Theranostics|June 10, 2016
MiR675-5p Acts on HIF-1α to Sustain Hypoxic Responses: A New Therapeutic Strategy for GliomaAlessia Lo Dico, Viviana Costa, Cristina Martelli, et al.
Pageof 6